首页 > 最新文献

Genetic Epidemiology最新文献

英文 中文
Fine-Mapping the Results From Genome-Wide Association Studies of Primary Biliary Cholangitis Using SuSiE and h2-D2 利用 Susie 和 h2-D2 对原发性胆汁性胆管炎的全基因组关联研究结果进行精细映射。
IF 1.7 4区 医学 Q3 GENETICS & HEREDITY Pub Date : 2024-10-06 DOI: 10.1002/gepi.22592
Aida Gjoka, Heather J. Cordell

The main goal of fine-mapping is the identification of relevant genetic variants that have a causal effect on some trait of interest, such as the presence of a disease. From a statistical point of view, fine mapping can be seen as a variable selection problem. Fine-mapping methods are often challenging to apply because of the presence of linkage disequilibrium (LD), that is, regions of the genome where the variants interrogated have high correlation. Several methods have been proposed to address this issue. Here we explore the ‘Sum of Single Effects’ (SuSiE) method, applied to real data (summary statistics) from a genome-wide meta-analysis of the autoimmune liver disease primary biliary cholangitis (PBC). Fine-mapping in this data set was previously performed using the FINEMAP program; we compare these previous results with those obtained from SuSiE, which provides an arguably more convenient and principled way of generating ‘credible sets’, that is set of predictors that are correlated with the response variable. This allows us to appropriately acknowledge the uncertainty when selecting the causal effects for the trait. We focus on the results from SuSiE-RSS, which fits the SuSiE model to summary statistics, such as z-scores, along with a correlation matrix. We also compare the SuSiE results to those obtained using a more recently developed method, h2-D2, which uses the same inputs. Overall, we find the results from SuSiE-RSS and, to a lesser extent, h2-D2, to be quite concordant with those previously obtained using FINEMAP. The resulting genes and biological pathways implicated are therefore also similar to those previously obtained, providing valuable confirmation of these previously reported results. Detailed examination of the credible sets identified suggests that, although for the majority of the loci (33 out of 56) the results from SuSiE-RSS seem most plausible, there are some loci (5 out of 56 loci) where the results from h2-D2 seem more compelling. Computer simulations suggest that, overall, SuSiE-RSS generally has slightly higher power, better precision, and better ability to identify the true number of causal variants in a region than h2-D2, although there are some scenarios where the power of h2-D2 is higher. Thus, in real data analysis, the use of complementary approaches such as both SuSiE and h2-D2 is potentially warranted.

精细作图的主要目标是识别对某些相关性状(如疾病的存在)具有因果效应的相关遗传变异。从统计学的角度来看,精细作图可以看作是一个变量选择问题。由于存在连锁不平衡(LD),即基因组中被检测变异具有高度相关性的区域,因此精细作图方法的应用往往具有挑战性。已经有几种方法被提出来解决这个问题。在此,我们探讨了 "单效应之和"(SuSiE)方法,并将其应用于对自身免疫性肝病原发性胆汁性胆管炎(PBC)进行的全基因组荟萃分析的真实数据(汇总统计)。我们将以前的结果与 SuSiE 得出的结果进行了比较,SuSiE 为生成 "可信集"(即与响应变量相关的预测因子集)提供了一种可以说更方便、更有原则的方法。这使我们在选择特质的因果效应时能够适当地承认不确定性。我们将重点放在 SuSiE-RSS 的结果上,它将 SuSiE 模型与 z 分数等汇总统计量以及相关矩阵进行拟合。我们还将 SuSiE 的结果与最近开发的方法 h2-D2 的结果进行了比较,后者使用了相同的输入。总的来说,我们发现 SuSiE-RSS 的结果与之前使用 FINEMAP 得出的结果非常一致,而 h2-D2 的结果则稍逊一筹。因此,得出的基因和生物通路也与之前得到的结果相似,为之前报告的结果提供了宝贵的证实。对已确定的可信数据集的详细研究表明,虽然对于大多数基因位点(56 个位点中的 33 个)来说,SuSiE-RSS 的结果似乎最可信,但在一些基因位点(56 个位点中的 5 个),h2-D2 的结果似乎更有说服力。计算机模拟表明,总体而言,与 h2-D2 相比,SuSiE-RSS 通常具有更高的功率、更高的精度和更强的能力来识别一个区域中因果变异的真实数量,尽管在某些情况下 h2-D2 的功率更高。因此,在实际数据分析中,可能需要同时使用 SuSiE 和 h2-D2 等互补方法。
{"title":"Fine-Mapping the Results From Genome-Wide Association Studies of Primary Biliary Cholangitis Using SuSiE and h2-D2","authors":"Aida Gjoka,&nbsp;Heather J. Cordell","doi":"10.1002/gepi.22592","DOIUrl":"10.1002/gepi.22592","url":null,"abstract":"<p>The main goal of fine-mapping is the identification of relevant genetic variants that have a causal effect on some trait of interest, such as the presence of a disease. From a statistical point of view, fine mapping can be seen as a variable selection problem. Fine-mapping methods are often challenging to apply because of the presence of linkage disequilibrium (LD), that is, regions of the genome where the variants interrogated have high correlation. Several methods have been proposed to address this issue. Here we explore the ‘Sum of Single Effects’ (SuSiE) method, applied to real data (summary statistics) from a genome-wide meta-analysis of the autoimmune liver disease primary biliary cholangitis (PBC). Fine-mapping in this data set was previously performed using the FINEMAP program; we compare these previous results with those obtained from SuSiE, which provides an arguably more convenient and principled way of generating ‘credible sets’, that is set of predictors that are correlated with the response variable. This allows us to appropriately acknowledge the uncertainty when selecting the causal effects for the trait. We focus on the results from SuSiE-RSS, which fits the SuSiE model to summary statistics, such as z-scores, along with a correlation matrix. We also compare the SuSiE results to those obtained using a more recently developed method, h2-D2, which uses the same inputs. Overall, we find the results from SuSiE-RSS and, to a lesser extent, h2-D2, to be quite concordant with those previously obtained using FINEMAP. The resulting genes and biological pathways implicated are therefore also similar to those previously obtained, providing valuable confirmation of these previously reported results. Detailed examination of the credible sets identified suggests that, although for the majority of the loci (33 out of 56) the results from SuSiE-RSS seem most plausible, there are some loci (5 out of 56 loci) where the results from h2-D2 seem more compelling. Computer simulations suggest that, overall, SuSiE-RSS generally has slightly higher power, better precision, and better ability to identify the true number of causal variants in a region than h2-D2, although there are some scenarios where the power of h2-D2 is higher. Thus, in real data analysis, the use of complementary approaches such as both SuSiE and h2-D2 is potentially warranted.</p>","PeriodicalId":12710,"journal":{"name":"Genetic Epidemiology","volume":"49 1","pages":""},"PeriodicalIF":1.7,"publicationDate":"2024-10-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/gepi.22592","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142380594","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
GWASBrewer: An R Package for Simulating Realistic GWAS Summary Statistics GWASBrewer:模拟真实 GWAS 摘要统计的 R 软件包
IF 1.7 4区 医学 Q3 GENETICS & HEREDITY Pub Date : 2024-10-06 DOI: 10.1002/gepi.22594
Jean Morrison

Many statistical genetics analysis methods make use of GWAS summary statistics. Best statistical practice requires evaluating these methods in realistic simulation experiments. However, simulating summary statistics by first simulating individual genotype and phenotype data is extremely computationally demanding. This high cost may force researchers to conduct overly simplistic simulations that fail to accurately measure method performance. Alternatively, summary statistics can be simulated directly from their theoretical distribution. Although this is a common need among statistical genetics researchers, no software packages exist for comprehensive GWAS summary statistic simulation. We present GWASBrewer, an open source R package for direct simulation of GWAS summary statistics. We show that statistics simulated by GWASBrewer have the same distribution as statistics generated from individual level data, and can be produced at a fraction of the computational expense. Additionally, GWASBrewer can simulate standard error estimates, something that is typically not done when sampling summary statistics directly. GWASBrewer is highly flexible, allowing the user to simulate data for multiple traits connected by causal effects and with complex distributions of effect sizes. We demonstrate example uses of GWASBrewer for evaluating Mendelian randomization, polygenic risk score, and heritability estimation methods.

许多统计遗传学分析方法都使用了 GWAS 摘要统计。最佳统计实践要求在实际模拟实验中评估这些方法。然而,通过首先模拟单个基因型和表型数据来模拟汇总统计量对计算要求极高。这种高成本可能会迫使研究人员进行过于简单的模拟,从而无法准确衡量方法的性能。另一种方法是直接从理论分布模拟汇总统计量。虽然这是统计遗传学研究人员的共同需求,但目前还没有软件包可用于全面的 GWAS 概要统计模拟。我们介绍了 GWASBrewer,这是一个直接模拟 GWAS 概要统计量的开源 R 软件包。我们的研究表明,GWASBrewer 模拟的统计量与从个体水平数据生成的统计量具有相同的分布,而且只需花费很少的计算费用即可生成。此外,GWASBrewer 还能模拟标准误差估计值,而这在直接对汇总统计数据进行采样时通常是做不到的。GWASBrewer 非常灵活,允许用户模拟由因果效应连接的多个性状的数据,以及效应大小的复杂分布。我们将举例说明 GWASBrewer 在评估孟德尔随机化、多基因风险评分和遗传率估计方法方面的应用。
{"title":"GWASBrewer: An R Package for Simulating Realistic GWAS Summary Statistics","authors":"Jean Morrison","doi":"10.1002/gepi.22594","DOIUrl":"10.1002/gepi.22594","url":null,"abstract":"<p>Many statistical genetics analysis methods make use of GWAS summary statistics. Best statistical practice requires evaluating these methods in realistic simulation experiments. However, simulating summary statistics by first simulating individual genotype and phenotype data is extremely computationally demanding. This high cost may force researchers to conduct overly simplistic simulations that fail to accurately measure method performance. Alternatively, summary statistics can be simulated directly from their theoretical distribution. Although this is a common need among statistical genetics researchers, no software packages exist for comprehensive GWAS summary statistic simulation. We present <span>GWASBrewer</span>, an open source R package for direct simulation of GWAS summary statistics. We show that statistics simulated by \u0000<span>GWASBrewer</span> have the same distribution as statistics generated from individual level data, and can be produced at a fraction of the computational expense. Additionally, \u0000<span>GWASBrewer</span> can simulate standard error estimates, something that is typically not done when sampling summary statistics directly. \u0000<span>GWASBrewer</span> is highly flexible, allowing the user to simulate data for multiple traits connected by causal effects and with complex distributions of effect sizes. We demonstrate example uses of \u0000<span>GWASBrewer</span> for evaluating Mendelian randomization, polygenic risk score, and heritability estimation methods.</p>","PeriodicalId":12710,"journal":{"name":"Genetic Epidemiology","volume":"49 1","pages":""},"PeriodicalIF":1.7,"publicationDate":"2024-10-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/gepi.22594","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142380595","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Mixed-Effect Kernel Machine Regression Model for Integrative Analysis of Alpha Diversity in Microbiome Studies 用于综合分析微生物组研究中阿尔法多样性的混合效应核机器回归模型。
IF 1.7 4区 医学 Q3 GENETICS & HEREDITY Pub Date : 2024-09-30 DOI: 10.1002/gepi.22596
Runzhe Li, Mo Li, Ni Zhao

Increasing evidence suggests that human microbiota plays a crucial role in many diseases. Alpha diversity, a commonly used summary statistic that captures the richness and/or evenness of the microbial community, has been associated with many clinical conditions. However, individual studies that assess the association between alpha diversity and clinical conditions often provide inconsistent results due to insufficient sample size, heterogeneous study populations and technical variability. In practice, meta-analysis tools have been applied to integrate data from multiple studies. However, these methods do not consider the heterogeneity caused by sequencing protocols, and the contribution of each study to the final model depends mainly on its sample size (or variance estimate). To combine studies with distinct sequencing protocols, a robust statistical framework for integrative analysis of microbiome datasets is needed. Here, we propose a mixed-effect kernel machine regression model to assess the association of alpha diversity with a phenotype of interest. Our approach readily incorporates the study-specific characteristics (including sequencing protocols) to allow for flexible modeling of microbiome effect via a kernel similarity matrix. Within the proposed framework, we provide three hypothesis testing approaches to answer different questions that are of interest to researchers. We evaluate the model performance through extensive simulations based on two distinct data generation mechanisms. We also apply our framework to data from HIV reanalysis consortium to investigate gut dysbiosis in HIV infection.

越来越多的证据表明,人类微生物群在许多疾病中起着至关重要的作用。α多样性是一种常用的概括统计量,可反映微生物群落的丰富度和/或均匀度,它与许多临床病症有关。然而,由于样本量不足、研究人群异质和技术上的差异,评估阿尔法多样性与临床症状之间关系的单项研究往往提供不一致的结果。实际上,荟萃分析工具已被用于整合多项研究的数据。然而,这些方法并没有考虑测序方案造成的异质性,每项研究对最终模型的贡献主要取决于其样本量(或方差估计值)。为了将不同测序方案的研究结合起来,需要一个强大的统计框架来综合分析微生物组数据集。在这里,我们提出了一种混合效应核机器回归模型,用于评估阿尔法多样性与感兴趣的表型之间的关联。我们的方法结合了研究的特定特征(包括测序方案),通过核相似性矩阵灵活地建立微生物组效应模型。在提议的框架内,我们提供了三种假设检验方法,以回答研究人员感兴趣的不同问题。我们通过基于两种不同数据生成机制的大量模拟来评估模型性能。我们还将我们的框架应用于艾滋病毒再分析联盟的数据,以研究艾滋病毒感染中的肠道菌群失调。
{"title":"A Mixed-Effect Kernel Machine Regression Model for Integrative Analysis of Alpha Diversity in Microbiome Studies","authors":"Runzhe Li,&nbsp;Mo Li,&nbsp;Ni Zhao","doi":"10.1002/gepi.22596","DOIUrl":"10.1002/gepi.22596","url":null,"abstract":"<div>\u0000 \u0000 <p>Increasing evidence suggests that human microbiota plays a crucial role in many diseases. Alpha diversity, a commonly used summary statistic that captures the richness and/or evenness of the microbial community, has been associated with many clinical conditions. However, individual studies that assess the association between alpha diversity and clinical conditions often provide inconsistent results due to insufficient sample size, heterogeneous study populations and technical variability. In practice, meta-analysis tools have been applied to integrate data from multiple studies. However, these methods do not consider the heterogeneity caused by sequencing protocols, and the contribution of each study to the final model depends mainly on its sample size (or variance estimate). To combine studies with distinct sequencing protocols, a robust statistical framework for integrative analysis of microbiome datasets is needed. Here, we propose a mixed-effect kernel machine regression model to assess the association of alpha diversity with a phenotype of interest. Our approach readily incorporates the study-specific characteristics (including sequencing protocols) to allow for flexible modeling of microbiome effect via a kernel similarity matrix. Within the proposed framework, we provide three hypothesis testing approaches to answer different questions that are of interest to researchers. We evaluate the model performance through extensive simulations based on two distinct data generation mechanisms. We also apply our framework to data from HIV reanalysis consortium to investigate gut dysbiosis in HIV infection.</p>\u0000 </div>","PeriodicalId":12710,"journal":{"name":"Genetic Epidemiology","volume":"49 1","pages":""},"PeriodicalIF":1.7,"publicationDate":"2024-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142345034","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Enhancing Gene Expression Predictions Using Deep Learning and Functional Annotations 利用深度学习和功能注释增强基因表达预测。
IF 1.7 4区 医学 Q3 GENETICS & HEREDITY Pub Date : 2024-09-30 DOI: 10.1002/gepi.22595
Pratik Ramprasad, Jingchen Ren, Wei Pan

Transcriptome-wide association studies (TWAS) aim to uncover genotype–phenotype relationships through a two-stage procedure: predicting gene expression from genotypes using an expression quantitative trait locus (eQTL) data set, then testing the predicted expression for trait associations. Accurate gene expression prediction in stage 1 is crucial, as it directly impacts the power to identify associations in stage 2. Currently, the first stage of such studies is primarily conducted using linear models like elastic net regression, which fail to capture the nonlinear relationships inherent in biological systems. Deep learning methods have the potential to model such nonlinear effects, but have yet to demonstrably outperform linear methods at this task. To address this gap, we propose a new deep learning architecture to predict gene expression from genotypic variation across individuals. Our method utilizes a learnable input scaling layer in conjunction with a convolutional encoder to capture nonlinear effects and higher-order interactions without compromising on interpretability. We further augment this approach to allow for parameter sharing across multiple networks, enabling us to utilize prior information for individual variants in the form of functional annotations. Evaluations on real-world genomic data show that our method consistently outperforms elastic net regression across a large set of heritable genes. Furthermore, our model statistically significantly improved predictive performance by leveraging functional annotations, whereas elastic net regression failed to show equivalent gains when using the same information, suggesting that our method can capture nonlinear functional information beyond the capability of linear models.

全转录组关联研究(TWAS)旨在通过两个阶段的程序发现基因型与表型之间的关系:使用表达量性状位点(eQTL)数据集根据基因型预测基因表达,然后测试预测表达与性状的关联。第一阶段准确的基因表达预测至关重要,因为它直接影响到第二阶段识别关联的能力。目前,此类研究的第一阶段主要使用弹性网回归等线性模型,而这些模型无法捕捉到生物系统固有的非线性关系。深度学习方法有可能为这种非线性效应建模,但在这项任务中还没有明显优于线性方法的表现。为了弥补这一差距,我们提出了一种新的深度学习架构,用于根据个体间的基因型变异预测基因表达。我们的方法利用可学习的输入缩放层与卷积编码器相结合,在不影响可解释性的前提下捕捉非线性效应和高阶交互作用。我们进一步增强了这种方法,允许在多个网络之间共享参数,使我们能够利用功能注释形式的个体变异先验信息。对真实世界基因组数据的评估表明,在大量遗传基因中,我们的方法始终优于弹性网回归。此外,通过利用功能注释,我们的模型在统计学上显著提高了预测性能,而弹性网回归在使用相同信息时未能显示出同等的收益,这表明我们的方法可以捕捉线性模型无法捕捉的非线性功能信息。
{"title":"Enhancing Gene Expression Predictions Using Deep Learning and Functional Annotations","authors":"Pratik Ramprasad,&nbsp;Jingchen Ren,&nbsp;Wei Pan","doi":"10.1002/gepi.22595","DOIUrl":"10.1002/gepi.22595","url":null,"abstract":"<p>Transcriptome-wide association studies (TWAS) aim to uncover genotype–phenotype relationships through a two-stage procedure: predicting gene expression from genotypes using an expression quantitative trait locus (eQTL) data set, then testing the predicted expression for trait associations. Accurate gene expression prediction in stage 1 is crucial, as it directly impacts the power to identify associations in stage 2. Currently, the first stage of such studies is primarily conducted using linear models like elastic net regression, which fail to capture the nonlinear relationships inherent in biological systems. Deep learning methods have the potential to model such nonlinear effects, but have yet to demonstrably outperform linear methods at this task. To address this gap, we propose a new deep learning architecture to predict gene expression from genotypic variation across individuals. Our method utilizes a learnable input scaling layer in conjunction with a convolutional encoder to capture nonlinear effects and higher-order interactions without compromising on interpretability. We further augment this approach to allow for parameter sharing across multiple networks, enabling us to utilize prior information for individual variants in the form of functional annotations. Evaluations on real-world genomic data show that our method consistently outperforms elastic net regression across a large set of heritable genes. Furthermore, our model statistically significantly improved predictive performance by leveraging functional annotations, whereas elastic net regression failed to show equivalent gains when using the same information, suggesting that our method can capture nonlinear functional information beyond the capability of linear models.</p>","PeriodicalId":12710,"journal":{"name":"Genetic Epidemiology","volume":"49 1","pages":""},"PeriodicalIF":1.7,"publicationDate":"2024-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/gepi.22595","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142345035","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Powerful Rare-Variant Association Analysis of Secondary Phenotypes 对次级表型进行强大的罕见变异关联分析
IF 1.7 4区 医学 Q3 GENETICS & HEREDITY Pub Date : 2024-09-30 DOI: 10.1002/gepi.22589
Hanyun Liu, Hong Zhang

Most genome-wide association studies are based on case-control designs, which provide abundant resources for secondary phenotype analyses. However, such studies suffer from biased sampling of primary phenotypes, and the traditional statistical methods can lead to seriously distorted analysis results when they are applied to secondary phenotypes without accounting for the biased sampling mechanism. To our knowledge, there are no statistical methods specifically tailored for rare variant association analysis with secondary phenotypes. In this article, we proposed two novel joint test statistics for identifying secondary-phenotype-associated rare variants based on prospective likelihood and retrospective likelihood, respectively. We also exploit the assumption of gene-environment independence in retrospective likelihood to improve the statistical power and adopt a two-step strategy to balance statistical power and robustness. Simulations and a real-data application are conducted to demonstrate the superior performance of our proposed methods.

大多数全基因组关联研究都基于病例对照设计,这为次级表型分析提供了丰富的资源。然而,这类研究存在主要表型采样偏倚的问题,如果不考虑采样偏倚机制,将传统统计方法应用于次要表型,会导致分析结果严重失真。据我们所知,目前还没有专门用于罕见变异与次级表型关联分析的统计方法。在本文中,我们提出了两种新的联合检验统计方法,分别基于前瞻性似然法和回顾性似然法,用于识别与次级表型相关的罕见变异。我们还利用了回顾似然法中的基因-环境独立性假设来提高统计能力,并采用两步策略来平衡统计能力和稳健性。我们进行了模拟和实际数据应用,以证明我们提出的方法性能优越。
{"title":"Powerful Rare-Variant Association Analysis of Secondary Phenotypes","authors":"Hanyun Liu,&nbsp;Hong Zhang","doi":"10.1002/gepi.22589","DOIUrl":"10.1002/gepi.22589","url":null,"abstract":"<div>\u0000 \u0000 <p>Most genome-wide association studies are based on case-control designs, which provide abundant resources for secondary phenotype analyses. However, such studies suffer from biased sampling of primary phenotypes, and the traditional statistical methods can lead to seriously distorted analysis results when they are applied to secondary phenotypes without accounting for the biased sampling mechanism. To our knowledge, there are no statistical methods specifically tailored for rare variant association analysis with secondary phenotypes. In this article, we proposed two novel joint test statistics for identifying secondary-phenotype-associated rare variants based on prospective likelihood and retrospective likelihood, respectively. We also exploit the assumption of gene-environment independence in retrospective likelihood to improve the statistical power and adopt a two-step strategy to balance statistical power and robustness. Simulations and a real-data application are conducted to demonstrate the superior performance of our proposed methods.</p>\u0000 </div>","PeriodicalId":12710,"journal":{"name":"Genetic Epidemiology","volume":"49 1","pages":""},"PeriodicalIF":1.7,"publicationDate":"2024-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142345036","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ethical, Legal, and Social Implications of Gene-Environment Interaction Research 基因与环境相互作用研究的伦理、法律和社会影响。
IF 1.7 4区 医学 Q3 GENETICS & HEREDITY Pub Date : 2024-09-24 DOI: 10.1002/gepi.22591
Stephanie Calluori, Kaitlin Kirkpatrick Heimke, Charlisse Caga-anan, David Kaufman, Leah E. Mechanic, Kimberly A. McAllister

Many complex disorders are impacted by the interplay of genetic and environmental factors. In gene-environment interactions (GxE), an individual's genetic and epigenetic makeup impacts the response to environmental exposures. Understanding GxE can impact health at the individual, community, and population levels. The rapid expansion of GxE research in biomedical studies for complex diseases raises many unique ethical, legal, and social implications (ELSIs) that have not been extensively explored and addressed. This review article builds on discussions originating from a workshop held by the National Institute of Environmental Health Sciences (NIEHS) and the National Human Genome Research Institute (NHGRI) in January 2022, entitled: “Ethical, Legal, and Social Implications of Gene-Environment Interaction Research.” We expand upon multiple key themes to inform broad recommendations and general guidance for addressing some of the most unique and challenging ELSI in GxE research. Key takeaways include strategies and approaches for establishing sustainable community partnerships, incorporating social determinants of health and environmental justice considerations into GxE research, effectively communicating and translating GxE findings, and addressing privacy and discrimination concerns in all GxE research going forward. Additional guidelines, resources, approaches, training, and capacity building are required to further support innovative GxE research and multidisciplinary GxE research teams.

许多复杂的疾病都受到遗传和环境因素相互作用的影响。在基因-环境相互作用(GxE)中,个体的基因和表观遗传构成会影响对环境暴露的反应。了解 GxE 可以影响个人、社区和人群的健康。在针对复杂疾病的生物医学研究中,GxE 研究的迅速扩展引发了许多独特的伦理、法律和社会影响 (ELSI),而这些影响尚未得到广泛的探讨和解决。这篇综述文章以美国国家环境健康科学研究所(NIEHS)和美国国家人类基因组研究所(NHGRI)于 2022 年 1 月举办的题为 "基因-环境相互作用研究的伦理、法律和社会影响 "的研讨会上的讨论为基础。我们扩展了多个关键主题,为解决基因与环境相互作用研究中一些最独特、最具挑战性的 ELSI 问题提供了广泛的建议和一般指导。主要收获包括建立可持续社区伙伴关系的策略和方法、将健康的社会决定因素和环境正义因素纳入 GxE 研究、有效交流和转化 GxE 研究结果,以及在今后的所有 GxE 研究中解决隐私和歧视问题。需要更多的指导方针、资源、方法、培训和能力建设,以进一步支持创新性 GxE 研究和多学科 GxE 研究团队。
{"title":"Ethical, Legal, and Social Implications of Gene-Environment Interaction Research","authors":"Stephanie Calluori,&nbsp;Kaitlin Kirkpatrick Heimke,&nbsp;Charlisse Caga-anan,&nbsp;David Kaufman,&nbsp;Leah E. Mechanic,&nbsp;Kimberly A. McAllister","doi":"10.1002/gepi.22591","DOIUrl":"10.1002/gepi.22591","url":null,"abstract":"<p>Many complex disorders are impacted by the interplay of genetic and environmental factors. In gene-environment interactions (GxE), an individual's genetic and epigenetic makeup impacts the response to environmental exposures. Understanding GxE can impact health at the individual, community, and population levels. The rapid expansion of GxE research in biomedical studies for complex diseases raises many unique ethical, legal, and social implications (ELSIs) that have not been extensively explored and addressed. This review article builds on discussions originating from a workshop held by the National Institute of Environmental Health Sciences (NIEHS) and the National Human Genome Research Institute (NHGRI) in January 2022, entitled: “Ethical, Legal, and Social Implications of Gene-Environment Interaction Research.” We expand upon multiple key themes to inform broad recommendations and general guidance for addressing some of the most unique and challenging ELSI in GxE research. Key takeaways include strategies and approaches for establishing sustainable community partnerships, incorporating social determinants of health and environmental justice considerations into GxE research, effectively communicating and translating GxE findings, and addressing privacy and discrimination concerns in all GxE research going forward. Additional guidelines, resources, approaches, training, and capacity building are required to further support innovative GxE research and multidisciplinary GxE research teams.</p>","PeriodicalId":12710,"journal":{"name":"Genetic Epidemiology","volume":"49 1","pages":""},"PeriodicalIF":1.7,"publicationDate":"2024-09-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/gepi.22591","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142307513","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
PSAP-Genomic-Regions: A Method Leveraging Population Data to Prioritize Coding and Non-Coding Variants in Whole Genome Sequencing for Rare Disease Diagnosis PSAP-Genomic-Regions:利用群体数据优先处理全基因组测序中编码和非编码变异以诊断罕见病的方法。
IF 1.7 4区 医学 Q3 GENETICS & HEREDITY Pub Date : 2024-09-24 DOI: 10.1002/gepi.22593
Marie-Sophie C. Ogloblinsky, Ozvan Bocher, Chaker Aloui, Anne-Louise Leutenegger, Ozan Ozisik, Anaïs Baudot, Elisabeth Tournier-Lasserve, Helen Castillo-Madeen, Daniel Lewinsohn, Donald F. Conrad, Emmanuelle Génin, Gaëlle Marenne

The introduction of Next-Generation Sequencing technologies in the clinics has improved rare disease diagnosis. Nonetheless, for very heterogeneous or very rare diseases, more than half of cases still lack molecular diagnosis. Novel strategies are needed to prioritize variants within a single individual. The Population Sampling Probability (PSAP) method was developed to meet this aim but only for coding variants in exome data. Here, we propose an extension of the PSAP method to the non-coding genome called PSAP-genomic-regions. In this extension, instead of considering genes as testing units (PSAP-genes strategy), we use genomic regions defined over the whole genome that pinpoint potential functional constraints. We conceived an evaluation protocol for our method using artificially generated disease exomes and genomes, by inserting coding and non-coding pathogenic ClinVar variants in large data sets of exomes and genomes from the general population. PSAP-genomic-regions significantly improves the ranking of these variants compared to using a pathogenicity score alone. Using PSAP-genomic-regions, more than 50% of non-coding ClinVar variants were among the top 10 variants of the genome. On real sequencing data from six patients with Cerebral Small Vessel Disease and nine patients with male infertility, all causal variants were ranked in the top 100 variants with PSAP-genomic-regions. By revisiting the testing units used in the PSAP method to include non-coding variants, we have developed PSAP-genomic-regions, an efficient whole-genome prioritization tool which offers promising results for the diagnosis of unresolved rare diseases.

下一代测序技术在临床上的应用改善了罕见病的诊断。然而,对于非常异质性或非常罕见的疾病,仍有一半以上的病例缺乏分子诊断。我们需要新的策略来确定单个个体内变异的优先次序。为实现这一目标,我们开发了群体采样概率(PSAP)方法,但该方法仅适用于外显子组数据中的编码变异。在这里,我们提出将 PSAP 方法扩展到非编码基因组,称为 PSAP-基因组-区域。在这一扩展中,我们不再将基因作为测试单元(PSAP-基因策略),而是使用定义在整个基因组上的基因组区域,以精确定位潜在的功能限制。我们设想了一个评估方案,利用人工生成的疾病外显子组和基因组,将编码和非编码致病性 ClinVar 变异插入来自普通人群的外显子组和基因组的大型数据集中,对我们的方法进行评估。与单独使用致病性评分相比,PSAP-基因组-区域能显著提高这些变异体的排序。使用 PSAP 基因组区域,50% 以上的 ClinVar 非编码变异跻身基因组前 10 个变异之列。在六名脑小血管疾病患者和九名男性不育症患者的真实测序数据中,所有因果变异都进入了使用 PSAP 基因组区域的前 100 个变异之列。通过重新审视 PSAP 方法中使用的检测单元,将非编码变异纳入其中,我们开发出了 PSAP-基因组-区域这一高效的全基因组优先排序工具,为诊断未解决的罕见病提供了可喜的成果。
{"title":"PSAP-Genomic-Regions: A Method Leveraging Population Data to Prioritize Coding and Non-Coding Variants in Whole Genome Sequencing for Rare Disease Diagnosis","authors":"Marie-Sophie C. Ogloblinsky,&nbsp;Ozvan Bocher,&nbsp;Chaker Aloui,&nbsp;Anne-Louise Leutenegger,&nbsp;Ozan Ozisik,&nbsp;Anaïs Baudot,&nbsp;Elisabeth Tournier-Lasserve,&nbsp;Helen Castillo-Madeen,&nbsp;Daniel Lewinsohn,&nbsp;Donald F. Conrad,&nbsp;Emmanuelle Génin,&nbsp;Gaëlle Marenne","doi":"10.1002/gepi.22593","DOIUrl":"10.1002/gepi.22593","url":null,"abstract":"<div>\u0000 \u0000 <p>The introduction of Next-Generation Sequencing technologies in the clinics has improved rare disease diagnosis. Nonetheless, for very heterogeneous or very rare diseases, more than half of cases still lack molecular diagnosis. Novel strategies are needed to prioritize variants within a single individual. The Population Sampling Probability (PSAP) method was developed to meet this aim but only for coding variants in exome data. Here, we propose an extension of the PSAP method to the non-coding genome called PSAP-genomic-regions. In this extension, instead of considering genes as testing units (PSAP-genes strategy), we use genomic regions defined over the whole genome that pinpoint potential functional constraints. We conceived an evaluation protocol for our method using artificially generated disease exomes and genomes, by inserting coding and non-coding pathogenic ClinVar variants in large data sets of exomes and genomes from the general population. PSAP-genomic-regions significantly improves the ranking of these variants compared to using a pathogenicity score alone. Using PSAP-genomic-regions, more than 50% of non-coding ClinVar variants were among the top 10 variants of the genome. On real sequencing data from six patients with Cerebral Small Vessel Disease and nine patients with male infertility, all causal variants were ranked in the top 100 variants with PSAP-genomic-regions. By revisiting the testing units used in the PSAP method to include non-coding variants, we have developed PSAP-genomic-regions, an efficient whole-genome prioritization tool which offers promising results for the diagnosis of unresolved rare diseases.</p></div>","PeriodicalId":12710,"journal":{"name":"Genetic Epidemiology","volume":"49 1","pages":""},"PeriodicalIF":1.7,"publicationDate":"2024-09-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142345037","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparing Ancestry Standardization Approaches for a Transancestry Colorectal Cancer Polygenic Risk Score 比较跨宗族结直肠癌多基因风险评分的宗族标准化方法。
IF 1.7 4区 医学 Q3 GENETICS & HEREDITY Pub Date : 2024-09-24 DOI: 10.1002/gepi.22590
Elisabeth A. Rosenthal, Li Hsu, Minta Thomas, Ulrike Peters, Christopher Kachulis, Karynne Patterson, Gail P. Jarvik

Colorectal cancer (CRC) is a complex disease with monogenic, polygenic and environmental risk factors. Polygenic risk scores (PRSs) aim to identify high polygenic risk individuals. Due to differences in genetic background, PRS distributions vary by ancestry, necessitating standardization. We compared four post-hoc methods using the All of Us Research Program Whole Genome Sequence data for a transancestry CRC PRS. We contrasted results from linear models trained on A. the entire data or an ancestrally diverse subset AND B. covariates including principal components of ancestry or admixture. Standardization with the training subset also adjusted the variance. All methods performed similarly within ancestry, OR (95% C.I.) per s.d. change in PRS: African 1.5 (1.02, 2.08), Admixed American 2.2 (1.27, 3.85), European 1.6 (1.43, 1.89), and Middle Eastern 1.1 (0.71, 1.63). Using admixture and an ancestrally diverse training set provided distributions closest to standard Normal. Training a model on ancestrally diverse participants, adjusting both the mean and variance using admixture as covariates, created standard Normal z-scores, which can be used to identify patients at high polygenic risk. These scores can be incorporated into comprehensive risk calculation including other known risk factors, allowing for more precise risk estimates.

结直肠癌(CRC)是一种复杂的疾病,具有单基因、多基因和环境风险因素。多基因风险评分(PRS)旨在识别多基因高风险个体。由于遗传背景的差异,PRS 的分布因血统而异,因此有必要进行标准化。我们使用 "全人类研究计划 "的全基因组序列数据比较了四种用于跨血统 CRC PRS 的事后分析方法。我们对比了 A. 整个数据或祖先多样性子集和 B. 辅变量(包括祖先或混血的主成分)所训练的线性模型的结果。用训练子集进行标准化还可以调整方差。所有方法在祖先、PRS 每 s.d. 变化的 OR(95% C.I.)方面的表现相似:非洲人 1.5 (1.02, 2.08),混血美国人 2.2 (1.27, 3.85),欧洲人 1.6 (1.43, 1.89),中东人 1.1 (0.71, 1.63)。使用掺杂和祖先多样化的训练集提供了最接近标准正态分布的分布。对祖先多样化的参与者进行模型训练,使用掺杂作为协变量来调整均值和方差,可得到标准正态 Z 值,用于识别多基因高风险患者。这些分数可以纳入包括其他已知风险因素在内的综合风险计算中,从而得出更精确的风险估计值。
{"title":"Comparing Ancestry Standardization Approaches for a Transancestry Colorectal Cancer Polygenic Risk Score","authors":"Elisabeth A. Rosenthal,&nbsp;Li Hsu,&nbsp;Minta Thomas,&nbsp;Ulrike Peters,&nbsp;Christopher Kachulis,&nbsp;Karynne Patterson,&nbsp;Gail P. Jarvik","doi":"10.1002/gepi.22590","DOIUrl":"10.1002/gepi.22590","url":null,"abstract":"<div>\u0000 \u0000 <p>Colorectal cancer (CRC) is a complex disease with monogenic, polygenic and environmental risk factors. Polygenic risk scores (PRSs) aim to identify high polygenic risk individuals. Due to differences in genetic background, PRS distributions vary by ancestry, necessitating standardization. We compared four <i>post-hoc</i> methods using the All of Us Research Program Whole Genome Sequence data for a transancestry CRC PRS. We contrasted results from linear models trained on A. the entire data or an ancestrally diverse subset AND B. covariates including principal components of ancestry or admixture. Standardization with the training subset also adjusted the variance. All methods performed similarly within ancestry, OR (95% C.I.) per s.d. change in PRS: African 1.5 (1.02, 2.08), Admixed American 2.2 (1.27, 3.85), European 1.6 (1.43, 1.89), and Middle Eastern 1.1 (0.71, 1.63). Using admixture and an ancestrally diverse training set provided distributions closest to standard Normal. Training a model on ancestrally diverse participants, adjusting both the mean and variance using admixture as covariates, created standard Normal <i>z</i>-scores, which can be used to identify patients at high polygenic risk. These scores can be incorporated into comprehensive risk calculation including other known risk factors, allowing for more precise risk estimates.</p>\u0000 </div>","PeriodicalId":12710,"journal":{"name":"Genetic Epidemiology","volume":"49 1","pages":""},"PeriodicalIF":1.7,"publicationDate":"2024-09-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142307512","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The 2024 Annual Meeting of the International Genetic Epidemiology Society 国际遗传流行病学学会 2024 年年会。
IF 1.7 4区 医学 Q3 GENETICS & HEREDITY Pub Date : 2024-09-23 DOI: 10.1002/gepi.22598
{"title":"The 2024 Annual Meeting of the International Genetic Epidemiology Society","authors":"","doi":"10.1002/gepi.22598","DOIUrl":"10.1002/gepi.22598","url":null,"abstract":"","PeriodicalId":12710,"journal":{"name":"Genetic Epidemiology","volume":"48 7","pages":"344-398"},"PeriodicalIF":1.7,"publicationDate":"2024-09-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142307514","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Predicting Lung Cancer in Korean Never-Smokers With Polygenic Risk Scores 用多基因风险评分预测韩国从不吸烟者的肺癌发病率
IF 1.7 4区 医学 Q3 GENETICS & HEREDITY Pub Date : 2024-09-23 DOI: 10.1002/gepi.22586
Juyeon Kim, Young Sik Park, Jin Hee Kim, Yun-Chul Hong, Young-Chul Kim, In-Jae Oh, Sun Ha Jee, Myung-Ju Ahn, Jong-Won Kim, Jae-Joon Yim, Sungho Won

In the last few decades, genome-wide association studies (GWAS) with more than 10,000 subjects have identified several loci associated with lung cancer and these loci have been used to develop novel risk prediction tools for cancer. The present study aimed to establish a lung cancer prediction model for Korean never-smokers using polygenic risk scores (PRSs); PRSs were calculated using a pruning-thresholding-based approach based on 11 genome-wide significant single nucleotide polymorphisms (SNPs). Overall, the odds ratios tended to increase as PRSs were larger, with the odds ratio of the top 5% PRSs being 1.71 (95% confidence interval: 1.31–2.23) using the 40%–60% percentile group as the reference, and the area under the curve (AUC) of the prediction model being of 0.76 (95% confidence interval: 0.747–0.774). The receiver operating characteristic (ROC) curves of the prediction model with and without PRSs as covariates were compared using DeLong's test, and a significant difference was observed. Our results suggest that PRSs can be valuable tools for predicting the risk of lung cancer.

在过去的几十年里,对超过 10,000 名受试者进行的全基因组关联研究(GWAS)发现了多个与肺癌相关的基因位点,这些基因位点已被用于开发新型癌症风险预测工具。本研究旨在利用多基因风险评分(PRSs)为韩国从不吸烟者建立一个肺癌预测模型;PRSs 是基于 11 个全基因组重要的单核苷酸多态性(SNPs),采用剪枝-阈值法计算得出的。总体而言,PRS越大,几率比越大,以40%-60%百分位数组为参照,前5% PRS的几率比为1.71(95%置信区间:1.31-2.23),预测模型的曲线下面积(AUC)为0.76(95%置信区间:0.747-0.774)。使用 DeLong 检验比较了以 PRS 为辅变量和不以 PRS 为辅变量的预测模型的接收器操作特征曲线(ROC),结果发现两者有显著差异。我们的研究结果表明,PRS 是预测肺癌风险的重要工具。
{"title":"Predicting Lung Cancer in Korean Never-Smokers With Polygenic Risk Scores","authors":"Juyeon Kim,&nbsp;Young Sik Park,&nbsp;Jin Hee Kim,&nbsp;Yun-Chul Hong,&nbsp;Young-Chul Kim,&nbsp;In-Jae Oh,&nbsp;Sun Ha Jee,&nbsp;Myung-Ju Ahn,&nbsp;Jong-Won Kim,&nbsp;Jae-Joon Yim,&nbsp;Sungho Won","doi":"10.1002/gepi.22586","DOIUrl":"10.1002/gepi.22586","url":null,"abstract":"<div>\u0000 \u0000 <p>In the last few decades, genome-wide association studies (GWAS) with more than 10,000 subjects have identified several loci associated with lung cancer and these loci have been used to develop novel risk prediction tools for cancer. The present study aimed to establish a lung cancer prediction model for Korean never-smokers using polygenic risk scores (PRSs); PRSs were calculated using a pruning-thresholding-based approach based on 11 genome-wide significant single nucleotide polymorphisms (SNPs). Overall, the odds ratios tended to increase as PRSs were larger, with the odds ratio of the top 5% PRSs being 1.71 (95% confidence interval: 1.31–2.23) using the 40%–60% percentile group as the reference, and the area under the curve (AUC) of the prediction model being of 0.76 (95% confidence interval: 0.747–0.774). The receiver operating characteristic (ROC) curves of the prediction model with and without PRSs as covariates were compared using DeLong's test, and a significant difference was observed. Our results suggest that PRSs can be valuable tools for predicting the risk of lung cancer.</p>\u0000 </div>","PeriodicalId":12710,"journal":{"name":"Genetic Epidemiology","volume":"49 1","pages":""},"PeriodicalIF":1.7,"publicationDate":"2024-09-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142284342","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Genetic Epidemiology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1